Prevention of cytomegalovirus infection and disease in high-risk renal transplant recipients with polyvalent intravenous immunoglobulins

Transplant Proc. 2002 May;34(3):812-3. doi: 10.1016/s0041-1345(01)02920-7.
No abstract available

MeSH terms

  • Cytomegalovirus / isolation & purification*
  • Cytomegalovirus Infections / drug therapy*
  • Cytomegalovirus Infections / epidemiology
  • Cytomegalovirus Infections / prevention & control
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use*
  • Kidney Transplantation / physiology*
  • Postoperative Complications / virology*
  • Retrospective Studies
  • Risk Factors

Substances

  • Immunoglobulins, Intravenous